In addition, the dosage of WDFY3 is affected in a subset of individuals with a rare chromosome disorder known as 4q21 deletion syndrome [OMIM 613509], characterized by intellectual disabilities (ID), language impairment and congenital birth defects (Bonnet et al., 2010; Cooper et al., 2011). The gene discussed is WDFY3; the disease is Intellectual disability.